Cooley, Zhong Lun and Maples and Calder, advised STAR CM on the deal. STAR CM, a variety program intellectual property creator and operator, announced its HK$390 million...
You must be a Standard 1 Year member to access this content.
Cooley advised the joint sponsors and underwriters on the deal while O’Melveny represented Cryofocus Medtech (Shanghai) Co., Ltd. Cryofocus Medtech announced its HK$210 million ($27 million) initial...
You must be a Standard 1 Year member to access this content.
Cooley advised Snyk on the deal while Orrick represented the investors. Snyk, a cybersecurity software startup, announced its $196.5 million Series G funding round. The round was...
You must be a Standard 1 Year member to access this content.
Cooley advised 645 Ventures on the deal. 645 Ventures, an early-stage venture capital firm, announced the formation of its oversubscribed fourth fund, 645 Ventures IV, and...
You must be a Standard 1 Year member to access this content.
Sidley advised Akeso Inc. on the deal. Akeso Inc. announced a high-profile US$5 billion collaboration and licensing agreement with Summit Therapeutics Inc. to out-license its breakthrough bispecific...
You must be a Standard 1 Year member to access this content.
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
You must be a Standard 1 Year member to access this content.
Cooley advised Avant on the deal. Avant, a credit-first financial technology company, announced that it secured $250 million of corporate debt and redeemable preferred equity from...
You must be a Standard 1 Year member to access this content.
Cooley advised Drata on the deal. Drata, a continuous security and compliance automation platform, announced its $200 million Series C funding round. The latest round of funding,...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Apollo Endosurgery on the deal, while Shearman & Sterling advised Boston Scientific Corporation. Apollo Endosurgery, a medical device company, signed the agreement to be...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055...
You must be a Standard 1 Year member to access this content.
Cooley advised Neogene Therapeutics on the deal. Neogene Therapeutics, a global clinical-stage biotechnology company, signed its definitive agreement to be acquired by AstraZeneca for a total consideration...
You must be a Standard 1 Year member to access this content.
Cooley represented Zoetis, while Davis Polk advised the joint book-running managers in the offering. Zoetis Inc. executed its offering of $600 million aggregate principal amount of its...
You must be a Standard 1 Year member to access this content.
